Caricamento...
Loss of immune tolerance to IL-2 in type 1 diabetes
Type 1 diabetes (T1D) is characterized by a chronic, progressive autoimmune attack against pancreas-specific antigens, effecting the destruction of insulin-producing β-cells. Here we show interleukin-2 (IL-2) is a non-pancreatic autoimmune target in T1D. Anti-IL-2 autoantibodies, as well as T cells...
Salvato in:
Pubblicato in: | Nat Commun |
---|---|
Autori principali: | , , , , , , , , , , , , , , , , , , , , , , |
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Nature Publishing Group
2016
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5059699/ https://ncbi.nlm.nih.gov/pubmed/27708334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms13027 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|